Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
This study is ongoing, but not recruiting participants.
Study NCT01252810   Information provided by GE Healthcare

First Received on December 1, 2010.   Last Updated on March 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
GE-145
Sponsors listed in this trial
GE Healthcare
i3 Statprobe
Medpace, Inc.
Biomedical Systems
Rules-Based Medicine (RBM)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services